Nanomaterials-Enhanced Electrochemical Biosensors for Epithelial Cancer Diagnosis: Recent Advances
Metadatos
Mostrar el registro completo del ítemAutor
Regiart, Matías; Giménez, Alba M.; Ortega, Francisco G.; Gómez, Germán E.; Sáinz Pérez, Juan; R. Tortella, Gonzalo; Fernández-Baldo, Martín-A.Editorial
MDPI
Materia
Biosensor Electrochemical Nanomaterial
Fecha
2025-11-22Referencia bibliográfica
Regiart, M.; Gimenez, A.M.; Ortega, F.G.; Gómez, G.E.; Sainz, J.; Tortella, G.R.; Fernández-Baldo, M.A. Nanomaterials-Enhanced Electrochemical Biosensors for Epithelial Cancer Diagnosis: Recent Advances. Biosensors 2025, 15, 766. https://doi.org/10.3390/bios15120766
Patrocinador
Universidad Nacional de San Luis (PROICO 02-2220); Agencia Nacional de Promoción Científica y Tecnológica (PICT-2021-GRF-TI-00136); Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) (PIP-11220200100033CO; Instituto de Salud Carlos III (ISCIII) (PI22_01275, CP23/00134, DTS23_00030); Universidad de Granada (P32/22/02)Resumen
In recent years, the interest in electrochemical biosensors has been constantly growing for
epithelial cancer diagnosis and prognosis. The incorporation of the different nanomaterials as metal nanoparticles, magnetic nanoparticles, carbon nanomaterials, Metal–Organic
Frameworks (MOFs), and nanocomposites, along with specific monoclonal antibodies, and
nucleic acids (aptamers) has improved both sensitivity and specificity in these methodologies. In this review, we have presented examples of electrochemical biosensors for the
determination of different epithelial cancer biomarkers. Based on numerous reports in the
recent literature, we highlight the use of single and multiplexed analytical platforms for
the quantification of epithelial cancer biomarkers. In addition, we outline potential development pathways, current challenges, and future prospects in the field of electrochemical
immuno-, apta-, and genosensors.





